CA Stock MarketDetailed Quotes

INNO InnoCan Pharma Corp

Watchlist

0.230
+0.005+2.22%

15min DelayMarket Closed Nov 15 09:30 ET

65.71MMarket Cap-10952P/E (TTM)

InnoCan Pharma Corp Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

53.84%5.19M

12.37%4.6M

-21.47%3.89M

-37.28%4.02M

-56.34%3.37M

-57.17%4.09M

-55.22%4.95M

9.38%6.42M

-Cash and cash equivalents

53.84%5.19M

12.37%4.6M

-21.47%3.89M

-37.28%4.02M

-56.34%3.37M

-57.17%4.09M

-55.22%4.95M

9.38%6.42M

Receivables

-11.75%398K

186.34%922K

185.60%694K

179.41%475K

81.12%451K

87.21%322K

-74.77%243K

30.77%170K

-Accounts receivable

12.50%18K

6.67%16K

13.33%17K

-64.41%21K

-46.67%16K

25.00%15K

--15K

--59K

-Taxes receivable

--0

218.75%408K

187.59%417K

123.81%188K

93.14%197K

15.32%128K

--145K

-1.18%84K

-Other receivables

59.66%380K

178.21%498K

213.25%260K

885.19%266K

103.42%238K

265.31%179K

-91.38%83K

-40.00%27K

Inventory

87.79%2.66M

103.12%2.6M

54.47%1.75M

73.68%1.68M

88.68%1.42M

129.57%1.28M

121.76%1.13M

96.55%969K

Prepaid assets

-50.60%206K

41.99%656K

-24.94%340K

-27.89%406K

-24.59%417K

-43.45%462K

--453K

15.13%563K

Restricted cash

2.94%105K

33.01%137K

32.69%138K

37.14%144K

-6.42%102K

1.98%103K

--104K

36.36%105K

Other current assets

--35K

----

Total current assets

49.20%8.59M

42.43%8.91M

-1.08%6.8M

-18.13%6.73M

-38.65%5.76M

-44.11%6.26M

-45.07%6.88M

16.56%8.22M

Non current assets

Net PPE

-14.08%122K

-9.22%128K

38.78%136K

44.09%134K

77.50%142K

58.43%141K

81.48%98K

43.08%93K

-Gross PPE

-14.08%122K

-9.22%128K

38.78%136K

44.09%134K

77.50%142K

58.43%141K

81.48%98K

43.08%93K

Total non current assets

-14.08%122K

-9.22%128K

38.78%136K

44.09%134K

77.50%142K

58.43%141K

81.48%98K

43.08%93K

Total assets

47.68%8.72M

41.29%9.04M

-0.52%6.94M

-17.44%6.87M

-37.66%5.9M

-43.30%6.4M

-44.52%6.98M

16.80%8.32M

Liabilities

Current liabilities

Current debt and capital lease obligation

----

57.14%22K

----

--14K

----

-Current capital lease obligation

----

57.14%22K

----

--14K

----

Payables

99.60%988K

145.13%1.59M

17.89%112K

28.60%679K

-29.99%495K

48.05%647K

-80.45%95K

14.04%528K

-accounts payable

119.77%389K

65.05%477K

17.89%112K

139.57%333K

-28.63%177K

87.66%289K

79.25%95K

61.63%139K

-Other payable

88.36%599K

209.78%1.11M

----

-11.05%346K

-30.72%318K

26.50%358K

----

3.18%389K

Current accrued expenses

----

45.60%463K

----

--318K

----

Other current liabilities

345.24%1.68M

609.84%2.74M

540.13%1.95M

233.07%1.67M

-76.33%378K

-81.52%386K

-90.12%304K

-81.43%502K

Current liabilities

205.96%2.67M

318.78%4.33M

247.88%2.54M

128.25%2.35M

-62.11%873K

-59.11%1.03M

-79.49%731K

-67.48%1.03M

Non current liabilities

Long term debt and capital lease obligation

-84.62%4K

-73.08%7K

-45.00%11K

-36.00%16K

116.67%26K

85.71%26K

--20K

--25K

-Long term capital lease obligation

-84.62%4K

-73.08%7K

-45.00%11K

-36.00%16K

116.67%26K

85.71%26K

--20K

--25K

Total non current liabilities

-84.62%4K

-73.08%7K

-45.00%11K

-36.00%16K

116.67%26K

85.71%26K

--20K

--25K

Total liabilities

197.55%2.68M

309.16%4.33M

240.08%2.55M

124.36%2.37M

-61.18%899K

-58.31%1.06M

-78.93%751K

-66.69%1.06M

Shareholders'equity

Share capital

--0

-common stock

--0

Additional paid-in capital

11.83%39.33M

10.94%38.95M

6.93%37.18M

5.37%36.49M

2.35%35.17M

2.88%35.11M

3.28%34.77M

23.68%34.63M

Retained earnings

-14.39%-34.5M

-17.53%-34.84M

-16.56%-33.07M

-18.49%-32.19M

-11.73%-30.16M

-17.35%-29.64M

-15.29%-28.37M

-13.02%-27.17M

Total stockholders'equity

-3.61%4.83M

-24.79%4.11M

-35.83%4.1M

-42.37%4.3M

-32.02%5.01M

-38.35%5.47M

-29.39%6.39M

88.37%7.47M

Noncontrolling interests

30,475.00%1.22M

569.29%596K

267.46%283K

195.15%196K

98.12%-4K

-4.10%-127K

-284.09%-169K

-1,772.73%-206K

Total equity

20.75%6.04M

-11.84%4.71M

-29.54%4.39M

-38.04%4.5M

-30.05%5M

-38.94%5.34M

-30.92%6.23M

83.68%7.26M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	53.84%5.19M	12.37%4.6M	-21.47%3.89M	-21.47%3.89M	-37.28%4.02M	-56.34%3.37M	-57.17%4.09M	-55.22%4.95M	-55.22%4.95M	9.38%6.42M
-Cash and cash equivalents	53.84%5.19M	12.37%4.6M	-21.47%3.89M	-21.47%3.89M	-37.28%4.02M	-56.34%3.37M	-57.17%4.09M	-55.22%4.95M	-55.22%4.95M	9.38%6.42M
Receivables	-11.75%398K	186.34%922K	185.60%694K	185.60%694K	179.41%475K	81.12%451K	87.21%322K	-74.77%243K	-74.77%243K	30.77%170K
-Accounts receivable	12.50%18K	6.67%16K	13.33%17K	13.33%17K	-64.41%21K	-46.67%16K	25.00%15K	--15K	--15K	--59K
-Taxes receivable	--0	218.75%408K	187.59%417K	187.59%417K	123.81%188K	93.14%197K	15.32%128K	--145K	--145K	-1.18%84K
-Other receivables	59.66%380K	178.21%498K	213.25%260K	213.25%260K	885.19%266K	103.42%238K	265.31%179K	-91.38%83K	-91.38%83K	-40.00%27K
Inventory	87.79%2.66M	103.12%2.6M	54.47%1.75M	54.47%1.75M	73.68%1.68M	88.68%1.42M	129.57%1.28M	121.76%1.13M	121.76%1.13M	96.55%969K
Prepaid assets	-50.60%206K	41.99%656K	-24.94%340K	-24.94%340K	-27.89%406K	-24.59%417K	-43.45%462K	--453K	--453K	15.13%563K
Restricted cash	2.94%105K	33.01%137K	32.69%138K	32.69%138K	37.14%144K	-6.42%102K	1.98%103K	--104K	--104K	36.36%105K
Other current assets	--35K	----	----	----	----	----	----	----	----	----
Total current assets	49.20%8.59M	42.43%8.91M	-1.08%6.8M	-1.08%6.8M	-18.13%6.73M	-38.65%5.76M	-44.11%6.26M	-45.07%6.88M	-45.07%6.88M	16.56%8.22M
Non current assets
Net PPE	-14.08%122K	-9.22%128K	38.78%136K	38.78%136K	44.09%134K	77.50%142K	58.43%141K	81.48%98K	81.48%98K	43.08%93K
-Gross PPE	-14.08%122K	-9.22%128K	38.78%136K	38.78%136K	44.09%134K	77.50%142K	58.43%141K	81.48%98K	81.48%98K	43.08%93K
Total non current assets	-14.08%122K	-9.22%128K	38.78%136K	38.78%136K	44.09%134K	77.50%142K	58.43%141K	81.48%98K	81.48%98K	43.08%93K
Total assets	47.68%8.72M	41.29%9.04M	-0.52%6.94M	-0.52%6.94M	-17.44%6.87M	-37.66%5.9M	-43.30%6.4M	-44.52%6.98M	-44.52%6.98M	16.80%8.32M
Liabilities
Current liabilities
Current debt and capital lease obligation	----	----	57.14%22K	57.14%22K	----	----	----	--14K	--14K	----
-Current capital lease obligation	----	----	57.14%22K	57.14%22K	----	----	----	--14K	--14K	----
Payables	99.60%988K	145.13%1.59M	17.89%112K	17.89%112K	28.60%679K	-29.99%495K	48.05%647K	-80.45%95K	-80.45%95K	14.04%528K
-accounts payable	119.77%389K	65.05%477K	17.89%112K	17.89%112K	139.57%333K	-28.63%177K	87.66%289K	79.25%95K	79.25%95K	61.63%139K
-Other payable	88.36%599K	209.78%1.11M	----	----	-11.05%346K	-30.72%318K	26.50%358K	----	----	3.18%389K
Current accrued expenses	----	----	45.60%463K	45.60%463K	----	----	----	--318K	--318K	----
Other current liabilities	345.24%1.68M	609.84%2.74M	540.13%1.95M	540.13%1.95M	233.07%1.67M	-76.33%378K	-81.52%386K	-90.12%304K	-90.12%304K	-81.43%502K
Current liabilities	205.96%2.67M	318.78%4.33M	247.88%2.54M	247.88%2.54M	128.25%2.35M	-62.11%873K	-59.11%1.03M	-79.49%731K	-79.49%731K	-67.48%1.03M
Non current liabilities
Long term debt and capital lease obligation	-84.62%4K	-73.08%7K	-45.00%11K	-45.00%11K	-36.00%16K	116.67%26K	85.71%26K	--20K	--20K	--25K
-Long term capital lease obligation	-84.62%4K	-73.08%7K	-45.00%11K	-45.00%11K	-36.00%16K	116.67%26K	85.71%26K	--20K	--20K	--25K
Total non current liabilities	-84.62%4K	-73.08%7K	-45.00%11K	-45.00%11K	-36.00%16K	116.67%26K	85.71%26K	--20K	--20K	--25K
Total liabilities	197.55%2.68M	309.16%4.33M	240.08%2.55M	240.08%2.55M	124.36%2.37M	-61.18%899K	-58.31%1.06M	-78.93%751K	-78.93%751K	-66.69%1.06M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Additional paid-in capital	11.83%39.33M	10.94%38.95M	6.93%37.18M	6.93%37.18M	5.37%36.49M	2.35%35.17M	2.88%35.11M	3.28%34.77M	3.28%34.77M	23.68%34.63M
Retained earnings	-14.39%-34.5M	-17.53%-34.84M	-16.56%-33.07M	-16.56%-33.07M	-18.49%-32.19M	-11.73%-30.16M	-17.35%-29.64M	-15.29%-28.37M	-15.29%-28.37M	-13.02%-27.17M
Total stockholders'equity	-3.61%4.83M	-24.79%4.11M	-35.83%4.1M	-35.83%4.1M	-42.37%4.3M	-32.02%5.01M	-38.35%5.47M	-29.39%6.39M	-29.39%6.39M	88.37%7.47M
Noncontrolling interests	30,475.00%1.22M	569.29%596K	267.46%283K	267.46%283K	195.15%196K	98.12%-4K	-4.10%-127K	-284.09%-169K	-284.09%-169K	-1,772.73%-206K
Total equity	20.75%6.04M	-11.84%4.71M	-29.54%4.39M	-29.54%4.39M	-38.04%4.5M	-30.05%5M	-38.94%5.34M	-30.92%6.23M	-30.92%6.23M	83.68%7.26M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

INNO InnoCan Pharma Corp

InnoCan Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow